Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation
The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Ebola virus (EBOV) infection blocks cellular production of alpha/beta interferon (IFN-α/β) and the ability of cells to respond to IFN-α/β or IFN-γ. The EBOV VP35 protein has previously been identified as an EBOV-encoded inhibitor of IFN-α/β production. However, the mechanism by which EBOV infection inhibits responses to IFNs has not previously been defined. Here we demonstrate that the EBOV VP24 protein functions as an inhibitor of IFN-α/β and IFN-γ signaling. Expression of VP24 results in an inhibition of IFN-induced gene expression and an inability of IFNs to induce an antiviral state. The VP24-mediated inhibition of cellular responses to IFNs correlates with the impaired nuclear accumulation of tyrosine-phosphorylated STAT1 (PY-STAT1), a key step in both IFN-α/β and IFN-γ signaling. Consistent with this proposed function for VP24, infection of cells with EBOV also confers a block to the IFN-induced nuclear accumulation of PY-STAT1. Further, VP24 is found to specifically interact with karyopherin α1, the nuclear localization signal receptor for PY-STAT1, but not with karyopherin α2, α3, or α4. Overexpression of VP24 results in a loss of karyopherin α1-PY-STAT1 interaction, indicating that the VP24-karyopherin α1 interaction contributes to the block to IFN signaling. These data suggest that VP24 is likely to be an important virulence determinant that allows EBOV to evade the antiviral effects of IFNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The sequestration of importins in the cytoplasm has been reported for other non-nuclear-replicating viruses, such as Ebola [58], as a means to inhibit interferon signaling.”
From Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection (2016) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
Functional classification of interferon-stimulated genes identified using microarrays
de Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., Silverman, R. H., & Williams, B. R. G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.912 · Cited by 900 · cited 1×
“(STAT1 is a key transcription factor in the IFN signaling pathways, and its expression is upregulated upon IFN- treatment [15, 37].”
BackgroundInterferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899 · cited 1×
“The nuclear localization of STAT1 (reviewed in references 47 and 49) is triggered by its tyrosine phosphorylation-induced, SH2 domain-dependent dimerization (23, 54, 57, 58).”
BackgroundShuai, K., Horvath, C. M., Huang, L. H. T., Qureshi, S. A., Cowburn, D., & Darnell, J. E. (1994) · Cell · doi:10.1016/0092-8674(94)90357-3 · Cited by 807 · cited 1×
“The nuclear localization of STAT1 (reviewed in references 47 and 49) is triggered by its tyrosine phosphorylation-induced, SH2 domain-dependent dimerization (23, 54, 57, 58).”
BackgroundActivation of Transcription by IFN-γ: Tyrosine Phosphorylation of a 91-kD DNA Binding Protein
Shuai, K., Schindler, C., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1281555 · Cited by 775 · cited 1×
“The nuclear localization of STAT1 (reviewed in references 47 and 49) is triggered by its tyrosine phosphorylation-induced, SH2 domain-dependent dimerization (23, 54, 57, 58).”
BackgroundLive attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
Jones, S. M., Feldmann, H., Ströher, U., Geisbert, J. B., Fernando, L., Grolla, A., Klenk, H.-D., Sullivan, N. J., Volchkov, V. E., Fritz, E. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1258 · Cited by 687 · cited 1×
“At present, no vaccines against EBOV are licensed for use in humans, although experimental vaccines that are effective in nonhuman primates have been described (34, 59, 60).”
BackgroundSelf-citationDevelopment of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663 · cited 1×
“At present, no vaccines against EBOV are licensed for use in humans, although experimental vaccines that are effective in nonhuman primates have been described (34, 59, 60).”
BackgroundPathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
Geisbert, T. W., Hensley, L. E., Larsen, T., Young, H. A., Reed, D. S., Geisbert, J. B., Scott, D. P., Kagan, E., Jahrling, P. B., & Davis, K. J. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63591-2 · Cited by 576
A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., & Huggins, J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515386 · Cited by 492 · cited 1×
“The IFN system has been clearly implicated in the susceptibility of mice to EBOV disease (9, 12, 42), and the sequence of VP24, along with that of several other genes, changed following the adaptation, by serial passage, of Zaire EBOV to mice (10).”
BackgroundThe Ebola virus VP35 protein functions as a type I IFN antagonist
Basler, C. F., Wang, X., Mühlberger, E., Volchkov, V., Paragas, J., Klenk, H.-D., García-Sastre, A., & Palese, P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220398297 · Cited by 478 · cited 13×
“To determine whether VP24 might globally block nuclear import, we determined whether it affected the localization of a GFP–IRF-3 fusion, which accumulates in the nucleus following Sendai virus infection.”
BackgroundMethodInfluentialSelf-citationThe Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3
Basler, C. F., Mikulasova, A., Martinez-Sobrido, L., Paragas, J., Mühlberger, E., Bray, M., Klenk, H.-D., Palese, P., & García-Sastre, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7945-7956.2003 · Cited by 477 · cited 13×
“To determine whether VP24 might globally block nuclear import, we determined whether it affected the localization of a GFP–IRF-3 fusion, which accumulates in the nucleus following Sendai virus infection.”
BackgroundMethodResultInfluentialSelf-citationAccelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
Sullivan, N. J., Geisbert, T. W., Geisbert, J. B., Xu, L., Yang, Z.-Y., Roederer, M., Koup, R. A., Jahrling, P. B., & Nabel, G. J. (2003) · Nature · doi:10.1038/nature01876 · Cited by 462 · cited 1×
“At present, no vaccines against EBOV are licensed for use in humans, although experimental vaccines that are effective in nonhuman primates have been described (34, 59, 60).”
BackgroundGreenlund, A. C., Farrar, M. A., Viviano, B. L., & Schreiber, R. D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06422.x · Cited by 454 · cited 1×
“The nuclear localization of STAT1 (reviewed in references 47 and 49) is triggered by its tyrosine phosphorylation-induced, SH2 domain-dependent dimerization (23, 54, 57, 58).”
BackgroundThe virus battles: IFN induction of the antiviral state and mechanisms of viral evasion
Levy, D. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00027-7 · Cited by 428 · cited 1×
“tion of numerous genes, some of which have antiviral properties (39).”
BackgroundNabel, G. J., Yang, Z., Duckers, H. J., Sullivan, N. J., Sanchez, A., & Nabel, E. G. (2000) · Nature Medicine · doi:10.1038/78645 · Cited by 413
Geisbert, T. W., Hensley, L. E., Jahrling, P. B., Larsen, T., Geisbert, J. B., Paragas, J., Young, H. A., Fredeking, T. M., Rote, W. E., & Vlasuk, G. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15012-x · Cited by 382 · cited 1×
“In addition, no antivirals are available to treat these severe infections, although an inhibitor of tissue factor was found to offer some protection to experimentally infected nonhuman primates (19).”
BackgroundPark, M.-S., Shaw, M. L., Muñoz-Jordan, J., Cros, J. F., Nakaya, T., Bouvier, N., Palese, P., García-Sastre, A., & Basler, C. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.2.1501-1511.2003 · Cited by 378 · cited 4×
“The ability of VP24 to inhibit IFN- signaling is demonstrated in Fig. 1A. In this experiment, Vero cells were cotransfected with the ISG54-CAT reporter and an empty expression plasmid or expression plasmids for the Nipah virus W protein, a previously demonstrated inhibitor of IFN signaling ( 50 , 56), FLAG-tagged VP24…”
BackgroundMethodInfluentialSelf-citationGeisbert, T. W., Young, H. A., Jahrling, P. B., Davis, K. J., Kagan, E., & Hensley, L. E. (2003) · The Journal of Infectious Diseases · doi:10.1086/379724 · Cited by 372 · cited 1×
“These include cytotoxicity of the viral glycoprotein, the production of proinflammatory cytokines, and the dysregulation of the coagulation cascade due to the production of tissue factor (14, 20, 21, 62, 64).”
BackgroundSekimoto, T. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.7067 · Cited by 358 · cited 4×
“(NLS) receptors, karyopherin 1 (importin 5) (45, 48, 55).”
BackgroundInfluentialCutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
Mahanty, S., Hutchinson, K., Agarwal, S., Mcrae, M., Rollin, P. E., & Pulendran, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.2797 · Cited by 354 · cited 1×
“Possible mechanisms contributing to this suppression include inhibition of dendritic cell activation and an induction of lymphocyte apoptosis (2, 8, 18, 22, 43).”
BackgroundHaspel, R. L., Salditt‐Georgieff, M., & Darnell, J. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01016.x · Cited by 312 · cited 1×
“Ultimately, nuclear STAT1 is dephosphorylated, dissociates from DNA, and is exported to the cytoplasm in a CRM1-dependent manner (29, 30, 44, 46, 47).”
BackgroundPathogenesis of filoviral haemorrhagic fevers
Mahanty, S., & Bray, M. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01103-x · Cited by 310 · cited 4×
“This extreme virulence has made Ebola and Marburg viruses of concern both as naturally emerging pathogens and as potential bioweapons (41).”
BackgroundInfluentialRodriguez, J. J., Parisien, J.-P., & Horvath, C. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11476-11483.2002 · Cited by 306 · cited 1×
“In a control sample, expression of the Nipah virus V protein, which has been shown to prevent STAT1 phosphorylation (52, 56), reduced the amount of PY-STAT1 (Fig.”
BackgroundcDNA structures and regulation of two interferon-induced human Mx proteins.
Aebi, M., Fäh, J., Hurt, N., Samuel, C. E., Thomis, D., Bazzigher, L., Pavlovic, J., Haller, O., & Staeheli, P. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.5062 · Cited by 305
Volchkov, V. E., Volchkova, V. A., Mühlberger, E., Kolesnikova, L. V., Weik, M., Dolnik, O., & Klenk, H.-D. (2001) · Science · doi:10.1126/science.1057269 · Cited by 303 · cited 1×
“These include cytotoxicity of the viral glycoprotein, the production of proinflammatory cytokines, and the dysregulation of the coagulation cascade due to the production of tissue factor (14, 20, 21, 62, 64).”
BackgroundSelf-citationApoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
Geisbert, T. W., Hensley, L. E., Gibb, T. R., Steele, K. E., Jaax, N. K., & Jahrling, P. B. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780021 · Cited by 302 · cited 1×
“Possible mechanisms contributing to this suppression include inhibition of dendritic cell activation and an induction of lymphocyte apoptosis (2, 8, 18, 22, 43).”
BackgroundBosio, C. M., Aman, M. J., Grogan, C., Hogan, R., Ruthel, G., Negley, D., Mohamadzadeh, M., Bavari, S., & Schmaljohn, A. (2003) · The Journal of Infectious Diseases · doi:10.1086/379199 · Cited by 296 · cited 2×
“quent studies confirm that VP35 exerts this function (8, 28).”
BackgroundRegulated nuclear import of the STAT1 transcription factor by direct binding of importin‐α
McBride, K. M., Banninger, G., McDonald, C., & Reich, N. C. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1754 · Cited by 289 · cited 6×
“by on January 30, 2010 jvi.asm.org Downloaded from ers (17, 45 ).”
BackgroundInfluentialJahrling, P. B., Geisbert, T. W., Geisbert, J. B., Swearengen, J. R., Bray, M., Jaax, N. K., Huggins, J. W., LeDuc, J. W., & Peters, C. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/514310 · Cited by 269 · cited 2×
“Although 200 IU/ml of IFN-2b was found to inhibit EBOV replication 100-fold in Vero cells (33), daily intramuscular treatment of EBOV-infected monkeys with a relatively high dose of IFN-2b beginning 18 h postinoculation merely delayed viremia and death by about 1 day ( 33 ).”
BackgroundBray, M., & Geisbert, T. W. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.02.018 · Cited by 265 · cited 1×
“Infection also appears to induce a general immune suppression (11, 53).”
BackgroundShaw, M. L., García-Sastre, A., Palese, P., & Basler, C. F. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5633-5641.2004 · Cited by 256 · cited 3×
“In a control sample, expression of the Nipah virus V protein, which has been shown to prevent STAT1 phosphorylation (52, 56 ), reduced the amount of PY-STAT1 (Fig. 4B).”
BackgroundMethodInfluentialSelf-citationHuang, Y., Xu, L., Sun, Y., & Nabel, G. J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00588-9 · Cited by 240 · cited 3×
“In the present study, we demonstrate that the Zaire EBOV VP24 protein, a minor viral structural protein previously implicated in viral nucleocapsid formation (31, 63), viral budding or assembly (3, 25), and host range determination (61), is capable of blocking both IFN- / and IFN- signaling.”
BackgroundLicata, J. M., Johnson, R. F., Han, Z., & Harty, R. N. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7344-7351.2004 · Cited by 236 · cited 3×
“When the expression of a constitutively-expressed Renilla luciferase gene was analyzed over the course of four independent transfections, luciferase values in IFN- -treated cells were not statistically different in VP24-expressing versus VP35- or VP40expressing cells (data not shown).”
BackgroundInfluentialThe role of the Type I interferon response in the resistance of mice to filovirus infection
Bray, M. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-6-1365 · Cited by 228 · cited 1×
“The IFN system has been clearly implicated in the susceptibility of mice to EBOV disease (9, 12, 42), and the sequence of VP24, along with that of several other genes, changed following the adaptation, by serial passage, of Zaire EBOV to mice (10).”
BackgroundYang, Z., Duckers, H. J., Sullivan, N. J., et al. (2000) · Nature Medicine · doi:10.1038/78654 · Cited by 214 · cited 1×
“These include cytotoxicity of the viral glycoprotein, the production of proinflammatory cytokines, and the dysregulation of the coagulation cascade due to the production of tissue factor (14, 20, 21, 62, 64).”
BackgroundLehtonen, A., Matikainen, S., & Julkunen, I. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.794 · Cited by 212 · cited 1×
“(STAT1 is a key transcription factor in the IFN signaling pathways, and its expression is upregulated upon IFN- treatment [15, 37].”
BackgroundKumar, K. P., McBride, K. M., Weaver, B. K., Dingwall, C., & Reich, N. C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4159-4168.2000 · Cited by 209 · cited 1×
“This selective interaction of VP24 with karyopherin 1 likely also explains why VP24 does not inhibit the nuclear import of IRF-3, as the nuclear import of this protein has been attributed to karyopherin 3 and 4 (36) (Fig.”
BackgroundDescriptive analysis of Ebola virus proteins
Elliott, L. H., Kiley, M. P., & McCormick, J. B. (1985) · Virology · doi:10.1016/0042-6822(85)90236-3 · Cited by 203 · cited 1×
“Early studies suggested that VP24 is found in EBOV virions and, as a consequence, VP24 was postulated to be a “minor matrix protein” or to function in viral uncoating (16, 53).”
BackgroundA nuclear protein tyrosine phosphatase is required for the inactivation of Stat1
Haspel, R. L., & Darnell, J. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10188 · Cited by 203 · cited 1×
“Ultimately, nuclear STAT1 is dephosphorylated, dissociates from DNA, and is exported to the cytoplasm in a CRM1-dependent manner (29, 30, 44, 46, 47).”
BackgroundNuclear export signal located within theDNA-binding domain of the STAT1transcription factor
McBride, K. M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.22.6196 · Cited by 196
Gupta, M., Mahanty, S., Ahmed, R., & Rollin, P. E. (2001) · Virology · doi:10.1006/viro.2001.0836 · Cited by 192
Fagerlund, R., Melén, K., Kinnunen, L., & Julkunen, I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202943200 · Cited by 183 · cited 1×
“by on January 30, 2010 jvi.asm.org Downloaded from ers ( 17 , 45).”
Melén, K., Fagerlund, R., Franke, J., Köhler, M., Kinnunen, L., & Julkunen, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303571200 · Cited by 174
Marg, A., Shan, Y., Meyer, T., Meissner, T., Brandenburg, M., & Vinkemeier, U. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403057 · Cited by 173 · cited 2×
“Ultimately, nuclear STAT1 is dephosphorylated, dissociates from DNA, and is exported to the cytoplasm in a CRM1-dependent manner (29, 30, 44, 46, 47).”
BackgroundMolecular Characterization of Guinea Pig-Adapted Variants of Ebola Virus
Volchkov, V. E., Chepurnov, A. A., Volchkova, V. A., Ternovoi, V. A., & Klenk, H. (2000) · Virology · doi:10.1006/viro.2000.0572 · Cited by 146 · cited 3×
“Sequence analysis of the VP24 gene from an independently adapted EBOV also identified an amino acid change in VP24, and it was suggested, based on these observations, that changes in VP24 are likely to play an important role in guinea pig adaptation (61).”
BackgroundSelf-citationHartman, A. L., Towner, J. S., & Nichol, S. T. (2004) · Virology · doi:10.1016/j.virol.2004.07.006 · Cited by 145 · cited 1×
“quent studies confirm that VP35 exerts this function (8, 28).”
BackgroundSelf-citationPathogenesis of Experimental Ebola Zaire Virus Infection in BALB/c Mice
Gibb, T. R., Bray, M., Geisbert, T. W., Steele, K. E., Kell, W. M., Davis, K. J., & Jaax, N. K. (2001) · Journal of Comparative Pathology · doi:10.1053/jcpa.2001.0502 · Cited by 144 · cited 1×
“Possible mechanisms contributing to this suppression include inhibition of dendritic cell activation and an induction of lymphocyte apoptosis (2, 8, 18, 22, 43).”
BackgroundHan, Z., Boshra, H., Sunyer, J. O., Zwiers, S. H., Paragas, J., & Harty, R. N. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.1793-1800.2003 · Cited by 134 · cited 4×
“In the present study, we demonstrate that the Zaire EBOV VP24 protein, a minor viral structural protein previously implicated in viral nucleocapsid formation (31, 63), viral budding or assembly (3, 25), and host range determination (61), is capable of blocking both IFN- / and IFN- signaling.”
BackgroundInfluentialWatanabe, S., Watanabe, T., Noda, T., Takada, A., Feldmann, H., Jasenosky, L. D., & Kawaoka, Y. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.999-1005.2004 · Cited by 133 · cited 2×
“In the present study, we demonstrate that the Zaire EBOV VP24 protein, a minor viral structural protein previously implicated in viral nucleocapsid formation (31, 63), viral budding or assembly (3, 25), and host range determination (61), is capable of blocking both IFN- / and IFN- signaling.”
BackgroundNucleocytoplasmic shuttling of STAT transcription factors
Meyer, T., & Vinkemeier, U. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04423.x · Cited by 131
Harcourt, B. H., Sanchez, A., & Offermann, M. K. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3491-3496.1999 · Cited by 113 · cited 6×
“Specifically, the up-regulation of several IFN-/- or IFN--induced genes was absent or reduced in the infected cells ( 27 ).”
BackgroundResultInfluentialHomo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein
Reid, S. P., Cardenas, W. B., & Basler, C. F. (2005) · Virology · doi:10.1016/j.virol.2005.06.044 · Cited by 104 · cited 1×
“We previously demonstrated that the EBOV VP35 protein suppresses IFN-/ production by inhibiting the activation of interferon regulatory factor 3 (IRF-3) (5, 7, 51 ), and subsequent studies confirm that VP35 exerts this function (8, 28).”
BackgroundSelf-citation3-Deazaneplanocin A induces massively increased interferon-α production in Ebola virus-infected mice
Bray, M., Raymond, J. L., Geisbert, T. W., & Baker, R. O. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00018-9 · Cited by 103
The beta-interferon promoter responds to priming through multiple independent regulatory elements.
King, P., & Goodbourn, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43857-4 · Cited by 96 · cited 5×
“The EBOV VP35 protein has previously been identified as an EBOV-encoded inhibitor of IFN- / production.”
BackgroundMethodInfluentialVP24 of Marburg Virus Influences Formation of Infectious Particles
Bamberg, S., Kolesnikova, L., Möller, P., Klenk, H., & Becker, S. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13421-13433.2005 · Cited by 96 · cited 2×
“In the present study, we demonstrate that the Zaire EBOV VP24 protein, a minor viral structural protein previously implicated in viral nucleocapsid formation (31, 63), viral budding or assembly (3, 25), and host range determination (61), is capable of blocking both IFN- / and IFN- signaling.”
BackgroundEbola Virus Inhibits Induction of Genes by Double-Stranded RNA in Endothelial Cells
Harcourt, B. H., Sanchez, A., & Offermann, M. K. (1998) · Virology · doi:10.1006/viro.1998.9446 · Cited by 93 · cited 1×
“EBOV encodes mechanisms to counteract the host interferon (IFN) response by blocking both production of IFN-/ and cellular responses to IFN-/ or - treatment (6, 24, 26 , 27).”
BackgroundMahanty, S., Gupta, M., Paragas, J., Bray, M., Ahmed, R., & Rollin, P. E. (2003) · Virology · doi:10.1016/s0042-6822(03)00233-2 · Cited by 80 · cited 4×
“For example, mouse-adapted Zaire EBOV is lethal to mice following intraperitoneal infection but not following subcutaneous infection (42).”
BackgroundInfluentialChan, S. Y., Ma, M. C., & Goldsmith, M. A. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-9-2155 · Cited by 79 · cited 1×
“These include cytotoxicity of the viral glycoprotein, the production of proinflammatory cytokines, and the dysregulation of the coagulation cascade due to the production of tissue factor (14, 20, 21, 62, 64).”
BackgroundThe Ins and Outs of STAT1 Nuclear Transport
McBride, K. M., & Reich, N. C. (2003) · Science's STKE · doi:10.1126/stke.2003.195.re13 · Cited by 75 · cited 1×
“Ultimately, nuclear STAT1 is dephosphorylated, dissociates from DNA, and is exported to the cytoplasm in a CRM1-dependent manner (29, 30, 44, 46, 47).”
BackgroundApoptosis in fatal Ebola infection. Does the virus toll the bell for immune system?
Baize, S., Leroy, E. M., Mavoungou, E., & Fisher‐Hoch, S. P. (2000) · APOPTOSIS · doi:10.1023/a:1009657006550 · Cited by 72 · cited 1×
“Possible mechanisms contributing to this suppression include inhibition of dendritic cell activation and an induction of lymphocyte apoptosis (2, 8, 18, 22, 43).”
BackgroundOutbreak of Marburg virus hemorrhagic fever--Angola, October 1, 2004-March 29, 2005.
(2005) · PubMed · Cited by 52
Huggins, J. W., Zhang, Z., & Monath, T. P. C. (1991) · Antiviral Research · doi:10.1016/0166-3542(91)90234-i · Cited by 14
Research works printed but not linked: 3
- 10.1128/mcb.9.11.5062-5072.1989 · doi:10.1128/mcb.9.11.5062-5072.1989 · Paper page
- Basler, C. F., and P. Palese. 2004. Modulation of innate immunity by filoviruses, p. 305-349. In H.-D. Klenk and H. Feldmann (ed.), Molecular and cellular biology of Marburg and Ebola viruses. Horizon Scientific Press, Norfolk, United Kingdom.
- Sanchez, A., A. S. Khan, S. R. Zaki, G. J. Nabel, T. G. Ksiazek, and C. J. Peters. 2001. Filoviridae: Marburg and Ebola viruses, p. 1279-1304. In B. N. Fields and D. M. Knipe (ed.), Fields virology, 4th ed., vol. 1. Lippincott Williams and Wilkins, Philadelphia, Pa.
Cited by
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
“However, as with the NS1 protein of influenza A viruses (below), the importance of the dsRNAbinding activity of the VP35 protein of EBOV in blocking IFN induction is not clear (Cardenas et al., 2006; Feng et al., 2007).”
BackgroundInfluentialFeldmann, H., & Geisbert, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)60667-8 · Cited by 1,374
Jacob, S. T., Crozier, I., Fischer, W. A., Hewlett, A., Kraft, C. S., Vega, M.-A. D. L., Soka, M. J., Wahl, V., Griffiths, A., Bollinger, L., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0147-3 · Cited by 664
Kopecky-Bromberg, S. A., Martínez-Sobrido, L., Frieman, M., Baric, R. A., & Palese, P. (2007) · Journal of Virology · doi:10.1128/jvi.01782-06 · Cited by 673
“Ebola virus protein VP35 inhibits interferon by binding and sequestering double-stranded RNA, while VP24 inhibits interferon by preventing the nuclear accumulation of activated STAT1 (1, 18).”
BackgroundCrossing the Nuclear Envelope: Hierarchical Regulation of Nucleocytoplasmic Transport
Terry, L. J., Shows, E. B., & Wente, S. R. (2007) · Science · doi:10.1126/science.1142204 · Cited by 548
Metadata
- Authors
- Reid, S. P., Leung, L. W., Hartman, A. L., Martinez, O., Shaw, M. L., Carbonnelle, C., Volchkov, V. E., Nichol, S. T., & Basler, C. F.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Centers for Disease Control and Prevention (US)
- Lyon 1 Université (FR)
- Corresponding author
- Basler, Christopher F.
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2006-06
- Volume
- 80
- Issue
- 11
- Pages
- 5156-5167
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2136920638
- Cited by
- 463
- References
- 61
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 15 · 2023: 21 · 2022: 10 · 2021: 22 · 2020: 23 · 2019: 19 · 2018: 20 · 2017: 33 · 2016: 29 · 2015: 53 · 2014: 30 · 2013: 13 · 2012: 20
- FWCI
- 14.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ellison Medical Foundation
- Institut National de la Santé et de la Recherche Médicale
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- Ebola virus, VP24, interferon signaling, interferon-gamma signaling, type I interferon, viral evasion of innate immunity, antiviral state, protein-protein interaction, virulence factors
- MeSH terms
- Animals, Cell Line, Chlorocebus aethiops, Vero Cells, Viral Proteins, Signal Transduction, alpha Karyopherins, Ebolavirus, STAT1 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.